Insights On Trial Design

31. Chronic Lymphocytic Leukemia: Global Clinical Trial Landscape (2024) 8/19/2024

    CLL is slow-progressing leukemia primarily affecting older adults. Get the latest information on research, innovative therapies, and emerging clinical trials shaping CLL care by downloading this report.

32. Ocular Endpoint Protection In A Capital-Constrained Market 9/3/2025

    Ocular Endpoint Protection reframes data capture as a non-negotiable driver of efficiency, and sponsors who embed point-of-need (PON) into their protocols protect both their investment and results.

33. Tips For Conducting Early-Phase Cancer Trials In Australia 9/23/2025

    Fast-track your early-phase cancer trial in Australia with world-class sites, expert teams, and streamlined regulatory approval.

34. Factors Affecting Systemic Drug Exposure 1/22/2025

    The increasing number of drugs on the market leads to a greater potential for DDIs. Determining the extent of the interaction and associated risks is an important safety consideration.

35. Revitalizing Recruitment In A Lupus Rescue Study 9/11/2025

    Recruitment hurdles are overcome by leveraging engaged, data-sharing patient communities. See how a strategic, patient-centric approach delivered a pre-qualified clinical trial cohort quickly and efficiently.

36. RTSM And IRT Solutions For Clinical Trials 12/10/2025

    Global leader in RTSM/IRT, helping sponsors and CROs speed study start-up, optimize supply, and manage complex trials with confidence.

37. Who's In Charge? How To Ensure Effective Trial Oversight, Leadership 3/19/2025

    Gain valuable insights into the role of sponsor-side Clinical Operations leadership, the risks of over-relying on CROs, and key strategies for fostering collaboration between sponsors and partners.

38. From Bottlenecks To Breakthroughs: How AI Is Transforming Translation Timelines 9/12/2025

    Take a deeper look at AI-enabled translations and uncover how they are able to drive a remarkable 43% reduction in overall translation timelines.

39. Critical Imaging Risks In GLP-1 And Neurology Studies 4/3/2025

    In the evolving landscape of GLP-1 and neurology clinical trials, imaging has become a pivotal tool for evaluating both efficacy and safety. Delve into the early indicators of imaging-related challenges and insights into preclinical strategies for effective risk mitigation.

40. DCTs And Community-Based Research Execution And Compliance 5/28/2025

    The FDA's regulatory endorsement of DCTs enhances their credibility, offering a pathway to more inclusive and accessible clinical research that benefits both patients and sponsors.